Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The medication is typically administered as a weekly injection
Resiliencey by having multiple suppliers is not incentivised because you split volumes and lose economies of scale. In response, Novo has lowered its prices in India, and has also licensed Emcure Pharmaceuticals to market semaglutide injections in India, priced midway between the emerging generics and Novos branded medicines
Responsible prescribing starts with determining whether the treatment aligns with your individual health profile
doi: 10.1055/a-2007-2061 17 WolffenbuttelBHRBrugtsMPCatarigAMClarkAKokMLieverseAGet al
Why CDMO Changes Company Economics Old Indian Pharma Model: Focused on generic drugs and bulk APIs
